Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 14, 2026 16:15 ET | Source: Newcore Gold Ltd.

Newcore Gold Announces $10 Million Bought Deal Financing

NOT FOR DISTRIBUTION TO THE UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 14, 2026 (GLOBE NEWSWIRE) -- Newcore Gold Ltd. ("Newcore"...
May 14, 2026 16:00 ET | Source: McEwen Inc.

McEwen Copper Appoints Societe Generale as Financial Advisor for Project Debt Financing of Los Azules

TORONTO, May 14, 2026 (GLOBE NEWSWIRE) -- McEwen Copper Inc. ("McEwen Copper" or the "Company") today announced that it has retained Societe Generale, to act as its sole financial advisor in...
May 13, 2026 06:00 ET | Source: NVision Quantum

NVision Expands from Quantum Sensing to Quantum Computing to Accelerate Discovery and Validation of New Therapies

ULM, Germany, May 13, 2026 (GLOBE NEWSWIRE) -- NVision, a leader in quantum technologies for healthcare, today announced a $55 million Series B financing round anchored by Abbott. The company also...
May 12, 2026 09:29 ET | Source: Zodiac Partners II, LLC

Zodiac Partners II, LLC Launches a $46 million Tender Offer to Acquire Destination XL Group, Inc. for $0.82 Per Share in Cash

Urges DXL Shareholders to Secure Significant and Immediate Cash Value by Tenderinginto Zodiac’s Offer West Palm Beach FL, May 12, 2026 (GLOBE NEWSWIRE) -- Zodiac Partners II, LLC an acquisition...
May 11, 2026 16:02 ET | Source: LEEF Brands Inc.

LEEF Brands Closes Final Round of Oversubscribed US$9.3 Million Financing

LEEF Brands closes final round of oversubscribed financing, raising total gross proceeds of approximately US$9.3 million across both closings.
May 08, 2026 08:15 ET | Source: InflaRx N.V.

InflaRx Announces Closing of $150 Million Underwritten Offering of Ordinary Shares

Jena, Germany, May 08, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system,...
May 07, 2026 07:25 ET | Source: Kane Biotech Inc.

Kane Biotech Announces New Private Placement Offering

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 07, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or...
May 06, 2026 08:30 ET | Source: InflaRx N.V.

InflaRx Announces Pricing of $150 Million Underwritten Offering of Ordinary Shares

Jena, Germany, May 06, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system,...
May 05, 2026 08:45 ET | Source: Clene Inc.

Clene Announces $7 Million Underwritten Offering of Common Stock

SALT LAKE CITY, May 05, 2026 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene” or the “Company”) and its wholly owned subsidiary, Clene Nanomedicine, Inc., a late...
May 05, 2026 03:00 ET | Source: Cytospire

Cytospire Therapeutics announces oversubscribed £61 million ($83m) Series A financing to advance pipeline of first-in-class pan-gamma delta T cell engagers into clinical trials for the treatment of cancer

Series A financing led by 4BIO Capital, with major new investors Servier Ventures, Sound Bioventures, British Business Bank and Criteria Bio Ventures, supported by existing investors Abingworth and...